The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krasnopolskaya K.V.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology;
M.F. Vladimirsky Moscow Regional Clinical Research Institute;
Prior Reproductive Health Clinic

Garina A.O.

Moscow Regional Research Institute of Obstetrics and Gynecology;
Vladimirsky Moscow Regional Clinical Research Institute;
Bauman Moscow State Technical University

Burumkulova F.F.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Isakova K.M.

State budgetary institution of health care Moscow Region «Moscow Regional Scientific Research Institute of Obstetrics and Gynecology»

Kalseidova K.Sh.

Moscow Regional Research Institute of Obstetrics and Gynecology

The role of myo-inositol and calcium L-methylfolate in complex therapy of polycystic ovary syndrome

Authors:

Krasnopolskaya K.V., Garina A.O., Burumkulova F.F., Isakova K.M., Kalseidova K.Sh.

More about the authors

Journal: Russian Journal of Human Reproduction. 2022;28(6): 147‑154

DOI: 10.17116/repro202228061147

Read: 5023 times

Download PDF (RU)
Contact the author
Table of contents

THE ROLE OF MYO-INOSITOL AND CALCIUM L-METHYLFOLATE IN COMPLEX THERAPY OF POLYCYSTIC OVARY SYNDROME
THE ROLE OF MYO-INOSITOL AND CALCIUM L-METHYLFOLATE IN COMPLEX THERAPY OF POLYCYSTIC OVARY SYNDROME

To cite this article:

Krasnopolskaya KV, Garina AO, Burumkulova FF, Isakova KM, Kalseidova KSh. The role of myo-inositol and calcium L-methylfolate in complex therapy of polycystic ovary syndrome. Russian Journal of Human Reproduction. 2022;28(6):147‑154. (In Russ.)
https://doi.org/10.17116/repro202228061147

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Features of the course of indu­ced pregnancy during the transfer of a thawed embryo in women with poly­cystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(1):54-62
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79
Effe­ctiveness of using preventive and personalized technologies for obesity correction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):80-90
Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chro­nic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60
Safety asse­ssment of bariatric surgery in the Russian Fede­ration acco­rding to the Russian National Bariatric Regi­stry. Endo­scopic Surgery. 2025;(1):5-14
The depe­ndence of the ploidic status of embryos on the state of the spindle of oocyte divi­sion, asse­ssed using pola­rization microscopy in IVF programs in women with ovarian endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49
Adipocytokines as a predictor of the risk of adve­rse outcomes in patients with coro­nary heart disease and abdo­minal obesity after percutaneous coro­nary inte­rvention. Russian Journal of Preventive Medi­cine. 2025;(2):38-45
Characteristics of the myocardial stru­ctural and functional para­meters depe­nding on the meta­bolic phenotype of the Arkhangelsk city resi­dents. Russian Journal of Preventive Medi­cine. 2025;(2):53-60
Serum concentrations of irisin, erythroferrone, myostatin and inte­rleukin-6 in obese patients depe­nding on the presence of sarcopenia. Russian Journal of Preventive Medi­cine. 2025;(2):67-73
The effe­ctiveness evaluation of a single primary moti­vational counseling in patients with obesity and cardiovascular diseases. Russian Journal of Preventive Medi­cine. 2025;(2):80-86
Abstract:

Polycystic ovary syndrome (PCOS), accompanied by a complex of disorders, including hyperandrogenism, insulin resistance, obesity, menstrual irregularities and, as a result, anovulatory infertility phenotypes A and D of PCOS, manifested by oligomenorrhea and polycystic ovarian structure according to ultrasound data, continue to attract the attention of gynecologists, endocrinologists and reproductologists, since they have the most pronounced manifestations and represent the most difficult group among the heterogeneous group of patients with PCOS for the correction of infertility and metabolic disorders. The objective of this study was to analyze phenotypes A and D of PCOS based on the data of patients who applied to the Department of Reproductology of the Moscow Regional Research Institute of Obstetrics and Gynecology, with the problem of infertility, and to determine the incidence of insulin resistance, obesity, and to evaluate the effectiveness of therapy with myo-inositol and calcium L-methylfolate in complex application of various methods of restoring natural fertility.

Keywords:

polycystic ovary syndrome
infertility
oligomenorrhea
insulin resistance
obesity
myo-inositol and calcium L-methylfolate

Authors:

Krasnopolskaya K.V.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology;
M.F. Vladimirsky Moscow Regional Clinical Research Institute;
Prior Reproductive Health Clinic

Garina A.O.

Moscow Regional Research Institute of Obstetrics and Gynecology;
Vladimirsky Moscow Regional Clinical Research Institute;
Bauman Moscow State Technical University

Burumkulova F.F.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Isakova K.M.

State budgetary institution of health care Moscow Region «Moscow Regional Scientific Research Institute of Obstetrics and Gynecology»

Kalseidova K.Sh.

Moscow Regional Research Institute of Obstetrics and Gynecology

Received:

15.09.2022

Accepted:

09.10.2022

Close metadata

References:

  1. Morgante G, Massaro MG, Di Sabatino A, Cappelli V, De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecological Endocrinology. 2018;34(1):4-9.  https://doi.org/10.1080/09513590.2017.1370644
  2. Abashova EI, Shalina MA, Misharina EV, Tkachenko NN, Bulgakova OL. Clinical features of polycystic ovary syndrome phenotypes in women with normogonadotropic anovulation in reproductive age. Zhurnal akusherstva i zhenskikh boleznej. 2019;68(3):7-14. (In Russ.). https://doi.org/10.17816/JOWD6837-14
  3. Zhenskoe besplodie (sovremennye podkhody k diagnostike i lecheniyu): klinicheskie rekomendatsii (protokol lecheniya). Pis’mo Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 5 marta 2019 №15-4/I/2-1913. (In Russ.). Accessed September 25, 2022. https://rulaws.ru/acts/Pismo-Minzdrava-Rossii-ot-05.03.2019-N-15-4_I_2-1913/?ysclid=l9tnws39nd459676031
  4. Azziz R. Polycystic Ovary Syndrome. Obstetrics and Gynecology. 2018;132(2):321-336.  https://doi.org/10.1097/AOG.0000000000002698
  5. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertility and Sterility. 2009;91(5):1750-1754. https://doi.org/10.1016/j.fertnstert.2008.01.088
  6. Krasnopolskaya KV, Sokolova EA, Ershova IYu, Isakova KM. Recovery of fertility in the surgical treatment of patients with infertility and polycystic ovary syndrome, depending on the duration of the menstrual cycle and the phenotype of the syndrome. Rossiiskij vestnik akushera-ginekologa. 2020;20(4):88-94. (In Russ.). https://doi.org/10.17116/rosakush20202004188
  7. Regidor PA, Schindler AE, Lesoine B, Druckman R. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation. 2018;34(2):20170067. https://doi.org/10.1515/hmbci-2017-0067
  8. Bevilacqua A, Carlomagno G, Gerli S, Montanino Oliva M, Devroey P, Lanzone A, Soulange C, Facchinetti F, Carlo Di Renzo G, Bizzarri M, Hod M, Cavalli P, D’Anna R, Benvenga S, Chiu TT, Kamenov ZA. Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology — assisted reproduction technology. Gynecological Endocrinology. 2015;31(6):441-446.  https://doi.org/10.3109/09513590.2015.1006616
  9. Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology. 2018;182:27-36.  https://doi.org/10.1016/j.jsbmb.2018.04.008
  10. Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecological Endocrinology. 2013;29(4):375-379.  https://doi.org/10.3109/09513590.2012.743020
  11. Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sciences. 2019; 228:167-175.  https://doi.org/10.1016/j.lfs.2019.04.046
  12. Artini PG, Obino MER, Sergiampietri C, Pinelli S, Papini F, Casarosa E, Cela V. PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome. Expert Review of Endocrinology and Metabolism. 2018;13:87-98.  https://doi.org/10.1080/17446651.2018.1431122
  13. Wu JB, Zhai JF, Yang J. Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk. Genetics and Molecular Research. 2016;15(4). https://doi.org/10.4238/gmr15048570
  14. Xiong Y, Bian C, Lin X, Wang X, Xu K, Zhao X. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer. Bioscience Reports. 2020;40(7): BSR20200995. https://doi.org/10.1042/BSR20200995
  15. Qi Q, Zhang H, Yu M, Wang X, Wang Z, Xu L, Wang J, Mu H. [Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome]. Chinese Journal of Medical Genetics. 2015;32(3):400-404. (In Chinese). https://doi.org/10.3760/cma.j.issn.1003-9406.2015.03.022
  16. Feng W, Zhang Y, Pan Y, Zhang Y, Liu M, Huang Y, Xiao Y, Mo W, Jiao J, Wang X, Tian D, Yang L, Ma Y. Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women. Reproductive Biology and Endocrinology. 2021;19(1):5.  https://doi.org/10.1186/s12958-020-00688-8
  17. Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, de Jong FH, Fauser BC, Laven JS. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Human Reproduction. 2009;24(8): 2014-2022. https://doi.org/10.1093/humrep/dep113
  18. Tian Y, Zhao H, Chen H, Peng Y, Cui L, Du Y, Wang Z, Xu J, Chen ZJ. Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese women. International Journal of Clinical Endocrinology and Metabolism. 2016; 101(5):jc20153776. https://doi.org/10.1210/jc.2015-3776
  19. Nazarenko TA, Isakova KM. Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review). Problemy reproduktstii. 2018;24(4):33-36. (In Russ.). https://doi.org/10.17116/repro20182404133
  20. Macut D, Bjekić-Macut J, Rahelić D, Doknić M. Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice. 2017; 130:163-170.  https://doi.org/10.1016/j.diabres.2017.06.011
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.